afatinib Jun 6, 2019 TAPUR Study Investigators Report First Positive Findings, Pursuing Tissue-Agnostic Cohorts Premium Jun 2, 2019 ASCO Studies Highlight Potential of Antibodies in Overcoming Anti-EGFR Rx Resistance in NSCLC Premium Jun 14, 2018 Breast, Lung Cancer Genetics Highlight Mutations Linked to Drug Response, Prognosis Breaking News NCCN Adds Mirati Therapeutics' Krazati to Guidelines for KRAS-Mutant NSCLC With Brain Metastases European Commission Approves Libtayo in PD-L1-Positive Non-Small Cell Lung Cancer NICE Backs Merck's Keytruda for PD-L1-Expressing Cervical Cancer Genialis Closes $13M Series A Funding Round Breast Cancer Study Leads to New Susceptibility Gene, Potential Treatment Strategies Incyte's Pemazyre Approved in Japan for FGFR1-Positive Rare Blood Cancers
